Caister Academic Press

Anti-HIV Chemotherapy

HIV Chemotherapy: A Critical Review
Edited by: Salvatore T. Butera
An essential reference for scientists working on AIDS, HIV and other retroviruses.
Anti-HIV Chemotherapy is vital in the fight against AIDS and HIV infection.

Anti-HIV Chemotherapy

Anti-HIV Chemotherapy: Since the beginning of the AIDS pandemic nearly 50 million people have been infected with HIV and over 16 million have died of AIDS. Combination anti-HIV chemotherapy has dramatically reduced mortality rates and increased life expectancy in infected individuals. However anti-HIV chemotherapy has not eradicated AIDS: the endemic is merely contained in industrialized nations and continues unabated in developing countries. Since current anti-HIV chemotherapy drugs are virostatic rather than virotoxic, infected individuals must remain on drug therapy for life. This is a major problem since all of the existing anti-HIV chemotherapy drugs have side effects, some of which are serious and potentially fatal. In addition, the naturally occurring and extensive genetic variation found in HIV has led to the emergence of anti-HIV chemotherapy drug-resistant viruses. These challenges have prompted the urgent search for novel, molecular-based anti-HIV chemotherapy drugs and therapeutic strategies that target the different stages of viral infection of and interaction with the host.

Anti-HIV Chemotherapy Book

Anti HIV Chemotherapy Resources


Anti-HIV Chemotherapy
RNAi
Molecular Biology Gateway
Molecular Biology Resource
Molecular Biology Gateway

Molecular Biology Resources

Molecular Biology Gateway
PCR Information and links on PCR
PCR Protocols
Real-Time PCR
The Genome Gateway
The Genomics Gateway
The Protocols Gateway
New Molecular Biology Sites

Further reading